There were approximately8,374 people with SCDliving in New York in 2004-2008:\u2022\u202240% younger than 21 years\u2022\u202246% 21-50 years\u2022\u202214% 51 years and olderThere were 197 babiesborn with SCD in New Yorkin 2008:\u2022\u2022Race\u3bf\u3bf 89% Black or African-American\u3bf\u3bf 8% White\u3bf\u3bf 3% Other/Unknown race\u2022\u2022Ethnicity\u3bf\u3bf 11% Hispanic-American\u3bf\u3bf 89% Non-HispanicSCD affects all races andethnic groups. In NewYork, SCD occurs amongapproximately 1 outof every\u2022\u20221,259 births\u2022\u2022260 Black or African-American births\u2022\u202210,209 White births\u2022\u20222,714 Hispanic-AmericanbirthsCS238867_IPublication date retrieved from document propertie
archdischild-2013-303773 Sickle cell disease (SCD) is a single gene disorder causing a debilitating ...
Sickle cell disease (SCD) is an autosomal reces-sive disorder due to a point mutation in the sixth c...
Sickle cell disease (SCD) has become a paradigm of immigration hematology in Europe. Accurate up-to ...
There were approximately8,374 people with SCDliving in New York in 2004-2008:\u2022\u202240% younger...
There were approximately5,578 people with SCDliving in North Carolina in2004-2008:\u2022\u2022 39% y...
There were approximately5,578 people with SCDliving in North Carolinain 2004-2008:\u2022\u2022 39% y...
PurposeSickle cell disease is estimated to occur in 1:300\ue2\u20ac\u201c400 African-American births...
There wereapproximately 5,100people with SCD living inCalifornia in 2004-2008:\u2022\u2022 14% young...
There wereapproximately 5,100people with SCD living inCalifornia in 2004-2008:\u2022\u2022 14% young...
Persons with sickle cell trait (SCT) are heterozygous carriers of an abnormal f-globin gene that re...
Sickle cell disease (SCD) disproportionately affects Black or African American persons in the United...
Sickle cell disease (SCD) is an inherited hematologic disorder in which abnormal hemoglobin results ...
The Centers for Disease Control and Prevention (CDC) estimates that sickle cell disease (SCD) affect...
Sickle cell disease (SCD) is the most common severe genetid disease. It impacts approximately 7,000 ...
Objectives: To estimate the prevalence of children with sickle cell disease (SCD) in The Netherlands...
archdischild-2013-303773 Sickle cell disease (SCD) is a single gene disorder causing a debilitating ...
Sickle cell disease (SCD) is an autosomal reces-sive disorder due to a point mutation in the sixth c...
Sickle cell disease (SCD) has become a paradigm of immigration hematology in Europe. Accurate up-to ...
There were approximately8,374 people with SCDliving in New York in 2004-2008:\u2022\u202240% younger...
There were approximately5,578 people with SCDliving in North Carolina in2004-2008:\u2022\u2022 39% y...
There were approximately5,578 people with SCDliving in North Carolinain 2004-2008:\u2022\u2022 39% y...
PurposeSickle cell disease is estimated to occur in 1:300\ue2\u20ac\u201c400 African-American births...
There wereapproximately 5,100people with SCD living inCalifornia in 2004-2008:\u2022\u2022 14% young...
There wereapproximately 5,100people with SCD living inCalifornia in 2004-2008:\u2022\u2022 14% young...
Persons with sickle cell trait (SCT) are heterozygous carriers of an abnormal f-globin gene that re...
Sickle cell disease (SCD) disproportionately affects Black or African American persons in the United...
Sickle cell disease (SCD) is an inherited hematologic disorder in which abnormal hemoglobin results ...
The Centers for Disease Control and Prevention (CDC) estimates that sickle cell disease (SCD) affect...
Sickle cell disease (SCD) is the most common severe genetid disease. It impacts approximately 7,000 ...
Objectives: To estimate the prevalence of children with sickle cell disease (SCD) in The Netherlands...
archdischild-2013-303773 Sickle cell disease (SCD) is a single gene disorder causing a debilitating ...
Sickle cell disease (SCD) is an autosomal reces-sive disorder due to a point mutation in the sixth c...
Sickle cell disease (SCD) has become a paradigm of immigration hematology in Europe. Accurate up-to ...